TM4SF1 and non-small cell lung carcinoma: [41] demonstrated that in non-small cell lung cancer (NSCLC), transmembrane-4 L-six family member-1 (TM4SF1) regulates tumor sensitivity to chemotherapy drugs by regulating the expression of discoid domain receptor 1 (DDR1)/Akt/ERK/mTOR pathway.